A hearing will get underway in Delaware later today in the latest phase of GSK’s attempts to defend itself from allegations that its Zantac drug ... according to law firm Wisner Baum, which ...

The settlement is with 10 plaintiffs firms, including Watts Law Firm and Wisner Baum. GlaxoSmithKline has agreed to pay up to $2.2 billion to settle 80,000 Zantac lawsuits. Wednesday's ...

Onder Law Firm also represents Hughes. Eric Olson, partner with Olson Grimsley Kawanabe Hinchcliff & Murray in Denver. (Courtesy photo) Olson noted that, like the three other prior Zantac trials ...

The British drug giant has agreed to pay up to $2.2bn to settle tens of thousands of US lawsuits claiming its heartburn drug Zantac caused ... settlement deal with 10 law firms that represent ...

On Wednesday, GSK plc (NYSE:GSK) reached agreements with ten plaintiff firms representing approximately 80,000 Zantac product liability cases in the U.S. state courts. These cases account for 93% of ...

GSK has reached agreements with 10 plaintiff firms to settle around 80,000 state court product liability cases related to its heartburn medication, Zantac, for $2.2 billion. The agreements involve ...

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

By Brendan Pierson (Reuters) -The latest trial over claims that the discontinued heartburn drug Zantac causes cancer ended with a hung jury on Wednesday, as jurors in Chicago were unable to agree ...

Oct 1 (Reuters) - U.S. law firm Fennemore Craig said on Tuesday that it has absorbed a small technology-focused law firm as part of a push to integrate artificial intelligence into its work and ...

(Reuters) - British drugmaker GSK said on Wednesday it had agreed to settle two lawsuits in California that claimed its discontinued heartburn drug Zantac caused cancer. GSK does not admit to any ...

Recent surprise decisions have upended plaintiffs’ expectations on the toxic tort front. In Delaware, the top court is rehearing the trial court’s evidentiary ruling admitting plaintiffs’ experts’ ...

The cases represent about 93% of those against the company involving Zantac, GSK said Wednesday in a statement. Settling them is not an admission of liability, the company said. Plaintiffs had argued ...